Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
32 Cards in this Set
- Front
- Back
high-ceiling loop diuretics
|
proto: furosemide
others: ethacrynic acid (Edecrin) bumetanide (Bumex) torsemide (Demadex) |
|
high-ceiling loop diuretics MOA
|
work in the ascending loop of Henle
blocks reabsorption of sodium and chloride and to prevent reabsorption of water causes extensive diuresis even with severe renal impairment |
|
high-ceiling loop diuretics uses
|
used when there is an emergent need for rapid mobilizations of fluid
pulmonary edema caused by heart failure conditions not responsive to other diuretics, such as edema caused by liver, cardiac, or kidney disease, or hypertension used to treat hypercalcemia related to kidney stone formation |
|
high-ceiling loop diuretic adverse
|
dehydration, hypernatremia, hypochloremia
hypotension ototoxicity hypokalemia hyperglycemia, hyperuricemia, decrease in calcium and magnesium levels |
|
high-ceiling loop diuretic contraindications
|
pregnancy
diabetes or gout |
|
high-ceiling loop diuretics interactions
|
digoxin (Lanoxin) toxicity can occur in the presence of hypokalemia
concurrent use of antihypertensives can have additive hypotensive effect lithium carbonate serum levels can increase which may lead to toxicity if hyponatremia occurs due to the loop diuretic NSAIDS increase blood flow to kidney which reduces diuretic effect |
|
high-ceiling loop diuretic considerations
|
avoid adminstering late in the day to prevent nocturia
normal dosing time is 0800 and 1400 administer furosemide orally, IV bolus dose, or continuous IV infusion Infuse IV doses at 20mg/min or slower to avoid abrupt hypotension and hypovolemia monitor potassium, eat foods high in potassium monitor magnesium levels, blood glucose levels |
|
high-ceiling loop diuretic effectiveness
|
decrease in pulmonary or peripheral edema
weight loss decrease in BP increase in urine output |
|
thiazide diuretics
|
Proto: hydrochlorothiazide
others: chlorothiazide (Diuril) methyclothiazide (Enduron) thiazide-type diuretics: indapamide (Lozide, Lozil) chlorthalidone (Hygroton) metolazone (Zaroxolyn) |
|
thiazide diuretic MOA
|
work in the early distal convuluted tubule
blocks reabsorption of sodium and chloride, and prevents the reabsorption of water at this site promotes diuresis when renal function is not impaired |
|
thiazide diuretic use
|
often medication of first choice for essential hypertension
edema of mild-to-moderate heart failure and liver and kidney disease often used in combination with antihypertensive agents for blood pressure control |
|
thiazide diuretic adverse
|
dehydration
hypokalemia (< 3.5 mEq/l) hyperglycemia |
|
thiazide diuretic contraindications
|
pregnancy, lactation, breastfeeding
|
|
thiazide diuretics interactions
|
same as loop-diuretic meds
cause no risk of hearing loss and can be combined with ototoxic drugs |
|
thiazide diuretic considerations
|
monitor potassium levels
take meds first thing in the morning if twice daily is prescribed- make sure to give last dose no later than 1400 to prevent nocturia diet high in potassium and plenty of fluids take with or after meals if GI upset occurs alternate-day dosing can decrease electrolyte imbalances |
|
thiazide diuretic effectiveness
|
decrease in BP
decrease in edema Increase in urine output |
|
potassium-sparing diuretics
|
sprionolactone (Aldactone)
other meds: triamterene (Dyrentium) amiloride (Midamor) |
|
potassium-sparing diuretics MOA
|
block the action of aldosterone which results in potassium retention and the secretion of sodium and water
|
|
potassium-sparing diuretics uses
|
combined with other loop diuretics for potassium sparing effects
administered for heart failure therapeutic effects may take 12-8 hours |
|
postassium-sparing diuretic adverse
|
hyperkalemia (>5.0 mEq/l)- discontinue meds restrict potassium, administer insulin injections to drive potassium back into the cell
should not be administered with spirolactone caution with angiotensin-converting enzyme, angiotensin receptor blockers, and direct renin inhibtors because they may cause elevated potassium levels Endocrine effects |
|
potassium-sparing diuretics contraindications
|
hyperkalemia
severe kidney failure and anuria |
|
potassium-sparing diuretics interactions
|
concurrent use of ACE inhibitors increases risk of hyperkalemia
concurrent use of potassium supplements increase the risk of hyperkalemia |
|
potassium-sparing diuretic considerations
|
avoid salt substitutes that contain potassium
monitor BP and weight triameterine may turn urine a bluish color monitor potassium levels |
|
potassium-sparing diuretic effectiveness
|
weight loss, maintenance of normal potassium levels, decrease in blood pressure and edema
|
|
osmotic diuretics
|
mannitol (Osmitrol)
|
|
osmotic diuretics MOA
|
reduce intracranial pressure and intraocular pressure by raising serum osmolarity and drawing fluid back into the vascular and extravascular space
|
|
osmotic diuretics uses
|
prevent kidney failure in specific situations such as hypovolemic shock and severe hypotension, because mannitol is not reabsorbed and remains in the nephron, drawing off water, thus preserving urine flow and preventing kidney failure
decreases intracranial pressure caused by cerebral edema by drawing off fluid form the brain into the bloodstream decreases IOP promote sodium retention and water excretion in clients who have hyponatremia and fluid volume excess administered for the oliguria phase of acute kidney injury |
|
osmotic diuretic adverse
|
heart failure, pulmonary edema, kidney failure, fluid and electrolyte imbalances
|
|
osmotic diuretic contraindications
|
heart failure
|
|
osmotic diuretic interactions
|
lithium excretion through the kidneys is increased (monitor lithium levels)
|
|
osmotic diuretic considerations
|
administer mannitol through continuous IV infusion
monitor for signs of dehydration, acute kidney injury, and edema |
|
osmotic diuretic effectiveness
|
urine output of at least 30 mL/hour
serum creatinine between 0.6 to 1.2 mg/dL for men and 0.5-1.1 mg/dL for women BUN levels between 10-20 mg/dL decrease in intracranial pressure decrease in intraocular pressure |